Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types

Korean J Radiol. 2018 Sep-Oct;19(5):1000-1005. doi: 10.3348/kjr.2018.19.5.1000. Epub 2018 Aug 6.

Abstract

Objective: To evaluate the ultrasonography (US) features and clinical characteristics of columnar cell variant of papillary thyroid carcinoma (CCV-PTC) that can predict disease progression.

Materials and methods: Six cases of CCV-PTC were identified via surgical pathology analysis at our institution from 1994 to 2016. The histological, architectural, and cytological features met the diagnostic criteria of CCV-PTC. We reviewed the US features and clinicopathological findings in the six cases.

Results: An indolent clinical course was observed in four young female patients aged 27-34 years (median: 32 years), while two older patients aged 55 years or 70 years had an aggressive clinical course. All patients underwent total thyroidectomy and radioiodine therapy. The indolent group included patients with T1 and nodal metastasis, where the disease was not observed during the follow-up period (range: 8-17 years). On the other hand, a larger tumor size (1.8 cm and 6.0 cm), gross extrathyroidal extension to the muscle and lymph node, and distant metastasis were observed in the aggressive group. In one male patient, recurrence occurred immediately after operation, and this patient died 4 years after the diagnosis of thyroid cancer. Based on US, the individuals from the indolent group had a smooth margin, except for one. Both cases in the aggressive group had a microlobulated margin.

Conclusion: Favorable prognosis in CCV-PTC is observed in young patients with T1 staging and demonstrates a smooth margin at US. These US findings might help exclude the same treatment as the aggressive type in the indolent type of CCV-PTC.

Keywords: Histology; Papillary thyroid carcinoma; Prognosis; Ultrasonography.

MeSH terms

  • Adult
  • Aged
  • Biopsy, Fine-Needle
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Proto-Oncogene Proteins B-raf / genetics
  • Thyroid Cancer, Papillary / diagnosis*
  • Thyroid Cancer, Papillary / diagnostic imaging
  • Thyroid Cancer, Papillary / pathology
  • Thyroid Neoplasms / diagnosis*
  • Thyroid Neoplasms / diagnostic imaging
  • Thyroid Neoplasms / pathology
  • Ultrasonography

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf